

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.21635733 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.21635733 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.95694185 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.87814325 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.59481508 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13758966 |
| 7 | regulation of cholesterol homeostasis (GO:2000188) | 3.90264438 |
| 8 | positive thymic T cell selection (GO:0045059) | 3.56011692 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 3.53648015 |
| 10 | mannose metabolic process (GO:0006013) | 3.48824623 |
| 11 | urea metabolic process (GO:0019627) | 3.42849691 |
| 12 | urea cycle (GO:0000050) | 3.42849691 |
| 13 | negative regulation of cholesterol transport (GO:0032375) | 3.40381753 |
| 14 | negative regulation of sterol transport (GO:0032372) | 3.40381753 |
| 15 | positive regulation of histone deacetylation (GO:0031065) | 3.36709356 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.34406286 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30033047 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.27073629 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26289722 |
| 20 | embryonic process involved in female pregnancy (GO:0060136) | 3.23531050 |
| 21 | phospholipid homeostasis (GO:0055091) | 3.22803932 |
| 22 | response to muramyl dipeptide (GO:0032495) | 3.21649128 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 3.19583405 |
| 24 | phospholipid efflux (GO:0033700) | 3.19224932 |
| 25 | plasma lipoprotein particle assembly (GO:0034377) | 3.18801111 |
| 26 | kynurenine metabolic process (GO:0070189) | 3.16665422 |
| 27 | negative T cell selection (GO:0043383) | 3.16622450 |
| 28 | protein-lipid complex assembly (GO:0065005) | 3.11886582 |
| 29 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.11630181 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10464389 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.10464389 |
| 32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.10136037 |
| 33 | detection of other organism (GO:0098543) | 3.09904420 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 3.09323379 |
| 35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.06106041 |
| 36 | L-phenylalanine catabolic process (GO:0006559) | 3.06106041 |
| 37 | response to interleukin-15 (GO:0070672) | 3.05137265 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 3.04793763 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.04455958 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04455958 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04455958 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04455958 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.04455958 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04455958 |
| 45 | detection of bacterium (GO:0016045) | 3.02183381 |
| 46 | thymic T cell selection (GO:0045061) | 3.01639593 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 3.00354696 |
| 48 | response to peptidoglycan (GO:0032494) | 2.99971424 |
| 49 | pinocytosis (GO:0006907) | 2.99612450 |
| 50 | germinal center formation (GO:0002467) | 2.96804465 |
| 51 | protein carboxylation (GO:0018214) | 2.95923771 |
| 52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.95923771 |
| 53 | valine metabolic process (GO:0006573) | 2.95322654 |
| 54 | L-phenylalanine metabolic process (GO:0006558) | 2.94883802 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.94883802 |
| 56 | aromatic amino acid family catabolic process (GO:0009074) | 2.93691840 |
| 57 | regulation of protein activation cascade (GO:2000257) | 2.91737634 |
| 58 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.91659519 |
| 59 | complement activation, alternative pathway (GO:0006957) | 2.88233003 |
| 60 | indole-containing compound catabolic process (GO:0042436) | 2.87814599 |
| 61 | indolalkylamine catabolic process (GO:0046218) | 2.87814599 |
| 62 | tryptophan catabolic process (GO:0006569) | 2.87814599 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.86857580 |
| 64 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.84501834 |
| 65 | histone H3-K36 demethylation (GO:0070544) | 2.83693959 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83031393 |
| 67 | high-density lipoprotein particle remodeling (GO:0034375) | 2.80464059 |
| 68 | regulation of fibrinolysis (GO:0051917) | 2.79405125 |
| 69 | regulation of B cell differentiation (GO:0045577) | 2.77464699 |
| 70 | growth hormone receptor signaling pathway (GO:0060396) | 2.76637302 |
| 71 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.76263541 |
| 72 | regulation of complement activation (GO:0030449) | 2.75220246 |
| 73 | tryptophan metabolic process (GO:0006568) | 2.74673703 |
| 74 | cysteine metabolic process (GO:0006534) | 2.73551290 |
| 75 | lysine catabolic process (GO:0006554) | 2.72370719 |
| 76 | lysine metabolic process (GO:0006553) | 2.72370719 |
| 77 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72249905 |
| 78 | positive regulation of extracellular matrix organization (GO:1903055) | 2.71035078 |
| 79 | detection of external biotic stimulus (GO:0098581) | 2.67265823 |
| 80 | sulfur amino acid catabolic process (GO:0000098) | 2.66425277 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 2.65943868 |
| 82 | homocysteine metabolic process (GO:0050667) | 2.65282890 |
| 83 | T cell selection (GO:0045058) | 2.65112948 |
| 84 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.65045155 |
| 85 | regulation of necroptotic process (GO:0060544) | 2.61941599 |
| 86 | bile acid biosynthetic process (GO:0006699) | 2.61586888 |
| 87 | B cell receptor signaling pathway (GO:0050853) | 2.60037059 |
| 88 | protein localization to endosome (GO:0036010) | 2.59607184 |
| 89 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.59596852 |
| 90 | cellular extravasation (GO:0045123) | 2.59252594 |
| 91 | 2-oxoglutarate metabolic process (GO:0006103) | 2.58944051 |
| 92 | regulation of triglyceride catabolic process (GO:0010896) | 2.58794991 |
| 93 | negative regulation of lipid transport (GO:0032369) | 2.58403468 |
| 94 | reverse cholesterol transport (GO:0043691) | 2.56834628 |
| 95 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.55970773 |
| 96 | positive T cell selection (GO:0043368) | 2.55858986 |
| 97 | regulation of extracellular matrix disassembly (GO:0010715) | 2.55669019 |
| 98 | glyoxylate metabolic process (GO:0046487) | 2.55450819 |
| 99 | negative regulation of fatty acid transport (GO:2000192) | 2.54470307 |
| 100 | intestinal cholesterol absorption (GO:0030299) | 2.53534138 |
| 101 | regulation of cholesterol storage (GO:0010885) | 2.52709078 |
| 102 | plasma lipoprotein particle clearance (GO:0034381) | 2.52639865 |
| 103 | detection of molecule of bacterial origin (GO:0032490) | 2.51311880 |
| 104 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.51184218 |
| 105 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.50675714 |
| 106 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49006889 |
| 107 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.48265984 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 2.47404909 |
| 109 | response to type I interferon (GO:0034340) | 2.47274652 |
| 110 | natural killer cell differentiation (GO:0001779) | 2.47015435 |
| 111 | glycine metabolic process (GO:0006544) | 2.46960474 |
| 112 | serine family amino acid catabolic process (GO:0009071) | 2.46101122 |
| 113 | myeloid dendritic cell differentiation (GO:0043011) | 2.46070634 |
| 114 | tolerance induction (GO:0002507) | 2.45240506 |
| 115 | complement activation, classical pathway (GO:0006958) | 2.45143997 |
| 116 | type I interferon signaling pathway (GO:0060337) | 2.44948742 |
| 117 | cellular response to type I interferon (GO:0071357) | 2.44948742 |
| 118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44548646 |
| 119 | ethanol oxidation (GO:0006069) | 2.42510142 |
| 120 | hypotonic response (GO:0006971) | 2.41816760 |
| 121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.41589613 |
| 122 | cellular response to virus (GO:0098586) | 2.40956700 |
| 123 | cholesterol efflux (GO:0033344) | 2.40576541 |
| 124 | detection of biotic stimulus (GO:0009595) | 2.39268091 |
| 125 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.38512183 |
| 126 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.37696390 |
| 127 | bile acid metabolic process (GO:0008206) | 2.37391510 |
| 128 | regulation of response to interferon-gamma (GO:0060330) | 2.35044454 |
| 129 | negative regulation of interleukin-12 production (GO:0032695) | 2.34961551 |
| 130 | leukocyte aggregation (GO:0070486) | 2.34800911 |
| 131 | regulation of extracellular matrix organization (GO:1903053) | 2.34569035 |
| 132 | response to laminar fluid shear stress (GO:0034616) | 2.34372005 |
| 133 | modulation by symbiont of host cellular process (GO:0044068) | 2.34025221 |
| 134 | regulation of humoral immune response (GO:0002920) | 2.33861655 |
| 135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33851581 |
| 136 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.33197937 |
| 137 | regulation of apoptotic cell clearance (GO:2000425) | 2.33171156 |
| 138 | regulation of cholesterol transport (GO:0032374) | 2.32752317 |
| 139 | regulation of sterol transport (GO:0032371) | 2.32752317 |
| 140 | regulation of histone H3-K27 methylation (GO:0061085) | 2.32658764 |
| 141 | regulation of superoxide anion generation (GO:0032928) | 2.32619825 |
| 142 | low-density lipoprotein particle clearance (GO:0034383) | 2.31420503 |
| 143 | cellular response to growth hormone stimulus (GO:0071378) | 2.31177343 |
| 144 | regulation of leukocyte degranulation (GO:0043300) | 2.30845778 |
| 145 | positive regulation of protein deacetylation (GO:0090312) | 2.30200544 |
| 146 | macromolecular complex remodeling (GO:0034367) | 2.29435835 |
| 147 | neutrophil activation involved in immune response (GO:0002283) | 2.27463800 |
| 148 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.24695602 |
| 149 | regulation of T cell tolerance induction (GO:0002664) | 2.24027373 |
| 150 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.23445227 |
| 151 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.21310691 |
| 152 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.20175581 |
| 153 | regulation of necrotic cell death (GO:0010939) | 2.19463443 |
| 154 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.18793783 |
| 155 | positive regulation of interferon-alpha production (GO:0032727) | 2.18351193 |
| 156 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.17632208 |
| 157 | response to host (GO:0075136) | 2.16380196 |
| 158 | response to host defenses (GO:0052200) | 2.16380196 |
| 159 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.16380196 |
| 160 | regulation of tolerance induction (GO:0002643) | 2.16247189 |
| 161 | negative regulation of type 2 immune response (GO:0002829) | 2.16091602 |
| 162 | immunoglobulin mediated immune response (GO:0016064) | 2.14097076 |
| 163 | myeloid dendritic cell activation (GO:0001773) | 2.13567315 |
| 164 | T cell migration (GO:0072678) | 2.12379120 |
| 165 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.12070154 |
| 166 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.10873807 |
| 167 | negative regulation of necroptotic process (GO:0060546) | 2.10663576 |
| 168 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.09958857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.67070214 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.50843020 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41245076 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.40330145 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.35701395 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.15834569 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.06469048 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01632570 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.91970258 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75966124 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.39137977 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.38890409 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.25263767 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.21543837 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19121533 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.17985333 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.13463999 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.10148303 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.07377997 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98008009 |
| 21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.96832060 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90941909 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90665180 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90079163 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.89058952 |
| 26 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85042429 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84824309 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84327065 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84142008 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.83637475 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.83255173 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.82612496 |
| 33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82048725 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.81280532 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79863535 |
| 36 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.79609099 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.78840676 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76825872 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76184411 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.74989242 |
| 41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73798349 |
| 42 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70220001 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69702129 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69647915 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.66149306 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61311976 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59527003 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59354260 |
| 49 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55645231 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55237064 |
| 51 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48703681 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46468807 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45448641 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44337637 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43810425 |
| 56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.42123741 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41088226 |
| 58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.40928173 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39122606 |
| 60 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37778777 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36344410 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.34093916 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32444686 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32241918 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31974390 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31943990 |
| 67 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26653612 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23596190 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22218899 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21584822 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21185486 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20933079 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19274325 |
| 74 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18984112 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18792874 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18769291 |
| 77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15259348 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13544059 |
| 79 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13412341 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12637930 |
| 81 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10918410 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08411143 |
| 83 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08252488 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07410716 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06876322 |
| 86 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06610757 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05368395 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05252715 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05086803 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04542524 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04252810 |
| 92 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03704446 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03674304 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02316272 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02221971 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01653756 |
| 97 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.00448702 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99763358 |
| 99 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99057006 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98938411 |
| 101 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97966317 |
| 102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97927632 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97227540 |
| 104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97191885 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97100384 |
| 106 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96797826 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96057778 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94597838 |
| 109 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93540790 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93402708 |
| 111 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92595552 |
| 112 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91751978 |
| 113 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90979160 |
| 114 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86513860 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86461579 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84487645 |
| 117 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83884282 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83302253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.97107994 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.78328062 |
| 3 | MP0005365_abnormal_bile_salt | 2.95489542 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 2.77682470 |
| 5 | MP0005451_abnormal_body_composition | 2.65727058 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.63714770 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.55824714 |
| 8 | MP0009840_abnormal_foam_cell | 2.53985425 |
| 9 | MP0003252_abnormal_bile_duct | 2.43837082 |
| 10 | MP0000685_abnormal_immune_system | 2.36330836 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.27415806 |
| 12 | MP0001800_abnormal_humoral_immune | 2.18001883 |
| 13 | MP0003724_increased_susceptibility_to | 2.08602829 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.06337208 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.03852595 |
| 16 | MP0001873_stomach_inflammation | 2.00465025 |
| 17 | MP0005387_immune_system_phenotype | 1.98894016 |
| 18 | MP0001790_abnormal_immune_system | 1.98894016 |
| 19 | MP0003303_peritoneal_inflammation | 1.96035001 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 1.95448445 |
| 21 | MP0002166_altered_tumor_susceptibility | 1.94013725 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.93833377 |
| 23 | MP0002254_reproductive_system_inflammat | 1.93277516 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.93122528 |
| 25 | MP0005083_abnormal_biliary_tract | 1.92541281 |
| 26 | MP0008260_abnormal_autophagy | 1.92436397 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.87205345 |
| 28 | MP0000609_abnormal_liver_physiology | 1.77648356 |
| 29 | MP0003436_decreased_susceptibility_to | 1.75876713 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.73147118 |
| 31 | MP0004947_skin_inflammation | 1.71425245 |
| 32 | MP0005409_darkened_coat_color | 1.69268865 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.68076909 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.66685321 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.61149571 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.58347357 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.58173261 |
| 38 | MP0005671_abnormal_response_to | 1.56945525 |
| 39 | MP0002723_abnormal_immune_serum | 1.56317694 |
| 40 | MP0002398_abnormal_bone_marrow | 1.52896533 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.48019063 |
| 42 | MP0001819_abnormal_immune_cell | 1.46502904 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.45588751 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.44120239 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.39885733 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.39593913 |
| 47 | MP0003866_abnormal_defecation | 1.39050497 |
| 48 | MP0009278_abnormal_bone_marrow | 1.38359643 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.37749260 |
| 50 | MP0000716_abnormal_immune_system | 1.35614774 |
| 51 | MP0002009_preneoplasia | 1.35457147 |
| 52 | MP0005025_abnormal_response_to | 1.34969213 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.33993366 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.29585168 |
| 55 | MP0004510_myositis | 1.29407002 |
| 56 | MP0002722_abnormal_immune_system | 1.28656152 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.28385297 |
| 58 | MP0003828_pulmonary_edema | 1.25956271 |
| 59 | MP0002006_tumorigenesis | 1.25259002 |
| 60 | MP0002419_abnormal_innate_immunity | 1.22390816 |
| 61 | MP0009785_altered_susceptibility_to | 1.21915751 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.21443884 |
| 63 | MP0004381_abnormal_hair_follicle | 1.21121476 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.20548381 |
| 65 | MP0002429_abnormal_blood_cell | 1.18279615 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 1.18272228 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.18038135 |
| 68 | MP0001851_eye_inflammation | 1.15907244 |
| 69 | MP0002405_respiratory_system_inflammati | 1.15165898 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.14403706 |
| 71 | MP0001853_heart_inflammation | 1.12991435 |
| 72 | MP0008469_abnormal_protein_level | 1.12714793 |
| 73 | MP0005023_abnormal_wound_healing | 1.12175017 |
| 74 | MP0000598_abnormal_liver_morphology | 1.12096429 |
| 75 | MP0001849_ear_inflammation | 1.10570566 |
| 76 | MP0008961_abnormal_basal_metabolism | 1.07408623 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.05671993 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.05671993 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.05484775 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 1.04377623 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 1.02842536 |
| 82 | MP0002132_abnormal_respiratory_system | 0.99448294 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.98524269 |
| 84 | MP0006082_CNS_inflammation | 0.98433211 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.97341308 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.96227077 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.95036643 |
| 88 | MP0001958_emphysema | 0.93813532 |
| 89 | MP0005164_abnormal_response_to | 0.92555424 |
| 90 | MP0009763_increased_sensitivity_to | 0.92274546 |
| 91 | MP0010307_abnormal_tumor_latency | 0.91864077 |
| 92 | MP0005332_abnormal_amino_acid | 0.91680885 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.90835425 |
| 94 | MP0002796_impaired_skin_barrier | 0.90426109 |
| 95 | MP0002089_abnormal_postnatal_growth/wei | 0.86987772 |
| 96 | MP0003868_abnormal_feces_composition | 0.86450670 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.86426015 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.86263616 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.85338455 |
| 100 | MP0003091_abnormal_cell_migration | 0.84864441 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.83844150 |
| 102 | MP0004883_abnormal_blood_vessel | 0.83571470 |
| 103 | MP0009115_abnormal_fat_cell | 0.83276227 |
| 104 | MP0000604_amyloidosis | 0.83236111 |
| 105 | MP0003045_fibrosis | 0.83145846 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.81529024 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.80773303 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.80631956 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.79880080 |
| 110 | MP0009764_decreased_sensitivity_to | 0.79629759 |
| 111 | MP0000249_abnormal_blood_vessel | 0.79407784 |
| 112 | MP0002060_abnormal_skin_morphology | 0.79284688 |
| 113 | MP0003329_amyloid_beta_deposits | 0.78877358 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.73011764 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72385462 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.70607213 |
| 117 | MP0001915_intracranial_hemorrhage | 0.70513182 |
| 118 | MP0000858_altered_metastatic_potential | 0.70243499 |
| 119 | MP0002933_joint_inflammation | 0.69999642 |
| 120 | MP0006054_spinal_hemorrhage | 0.69316764 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.69117777 |
| 122 | MP0002928_abnormal_bile_duct | 0.69063316 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 0.68441549 |
| 124 | MP0000490_abnormal_crypts_of | 0.67546446 |
| 125 | MP0004130_abnormal_muscle_cell | 0.66278667 |
| 126 | MP0002019_abnormal_tumor_incidence | 0.64998680 |
| 127 | MP0005310_abnormal_salivary_gland | 0.60818417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.11074105 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 3.43632416 |
| 3 | Xanthomatosis (HP:0000991) | 3.41143406 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.33214128 |
| 5 | Myocardial infarction (HP:0001658) | 3.22744622 |
| 6 | Colitis (HP:0002583) | 3.19383245 |
| 7 | Abnormality of the fingertips (HP:0001211) | 3.08345913 |
| 8 | Recurrent viral infections (HP:0004429) | 2.99568229 |
| 9 | Gastrointestinal inflammation (HP:0004386) | 2.94607133 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 2.94491094 |
| 11 | Abnormality of macrophages (HP:0004311) | 2.93329347 |
| 12 | Inflammation of the large intestine (HP:0002037) | 2.92338285 |
| 13 | Flat acetabular roof (HP:0003180) | 2.91948130 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 2.80741942 |
| 15 | Gingival bleeding (HP:0000225) | 2.78517392 |
| 16 | Complement deficiency (HP:0004431) | 2.76277701 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.69622033 |
| 18 | Recurrent abscess formation (HP:0002722) | 2.68218758 |
| 19 | Myositis (HP:0100614) | 2.64315675 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.63492544 |
| 21 | Mitral stenosis (HP:0001718) | 2.59192792 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57846388 |
| 23 | Recurrent bronchitis (HP:0002837) | 2.55678304 |
| 24 | Orchitis (HP:0100796) | 2.55500584 |
| 25 | T lymphocytopenia (HP:0005403) | 2.54211050 |
| 26 | Pustule (HP:0200039) | 2.52565825 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 2.51125288 |
| 28 | Hematochezia (HP:0002573) | 2.50530731 |
| 29 | Esophageal varix (HP:0002040) | 2.49976272 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 2.49762620 |
| 31 | Abnormal platelet volume (HP:0011876) | 2.49468853 |
| 32 | Polycythemia (HP:0001901) | 2.48712649 |
| 33 | Thin bony cortex (HP:0002753) | 2.48225907 |
| 34 | Nasal polyposis (HP:0100582) | 2.46862253 |
| 35 | Chronic otitis media (HP:0000389) | 2.45323126 |
| 36 | Cerebral aneurysm (HP:0004944) | 2.42950882 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42849068 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.42801784 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.41749586 |
| 40 | Acanthocytosis (HP:0001927) | 2.40998897 |
| 41 | Gingivitis (HP:0000230) | 2.40714826 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.40354641 |
| 43 | Agammaglobulinemia (HP:0004432) | 2.40304890 |
| 44 | Increased mean platelet volume (HP:0011877) | 2.37232082 |
| 45 | Verrucae (HP:0200043) | 2.35665097 |
| 46 | Papilloma (HP:0012740) | 2.35665097 |
| 47 | Prolonged partial thromboplastin time (HP:0003645) | 2.31526141 |
| 48 | Hypolipoproteinemia (HP:0010981) | 2.28766074 |
| 49 | Abnormality of the nasal mucosa (HP:0000433) | 2.27937343 |
| 50 | IgM deficiency (HP:0002850) | 2.26593673 |
| 51 | Optic neuritis (HP:0100653) | 2.25734414 |
| 52 | Retrobulbar optic neuritis (HP:0100654) | 2.25734414 |
| 53 | Periodontitis (HP:0000704) | 2.23997495 |
| 54 | Joint hemorrhage (HP:0005261) | 2.23939834 |
| 55 | Protrusio acetabuli (HP:0003179) | 2.23203286 |
| 56 | Increased IgE level (HP:0003212) | 2.21359275 |
| 57 | Eczematoid dermatitis (HP:0000976) | 2.20237859 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.17913120 |
| 59 | Epistaxis (HP:0000421) | 2.17597693 |
| 60 | Poikilocytosis (HP:0004447) | 2.16703009 |
| 61 | Cellulitis (HP:0100658) | 2.15704781 |
| 62 | Dysostosis multiplex (HP:0000943) | 2.15013657 |
| 63 | Abnormality of T cells (HP:0002843) | 2.14351961 |
| 64 | Glomerulonephritis (HP:0000099) | 2.13401273 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13026549 |
| 66 | Panhypogammaglobulinemia (HP:0003139) | 2.12139587 |
| 67 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11518259 |
| 68 | Gastrointestinal stroma tumor (HP:0100723) | 2.11358788 |
| 69 | Arterial thrombosis (HP:0004420) | 2.09527573 |
| 70 | Epidermoid cyst (HP:0200040) | 2.09303598 |
| 71 | Aortic aneurysm (HP:0004942) | 2.08566345 |
| 72 | Subacute progressive viral hepatitis (HP:0006572) | 2.07998216 |
| 73 | Spastic diplegia (HP:0001264) | 2.07422356 |
| 74 | Impaired platelet aggregation (HP:0003540) | 2.05541722 |
| 75 | Abnormal platelet function (HP:0011869) | 2.05541722 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 2.05463920 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05382774 |
| 78 | Asymmetry of the thorax (HP:0001555) | 2.04632966 |
| 79 | Reticulocytosis (HP:0001923) | 2.04421110 |
| 80 | Fatigue (HP:0012378) | 2.03861903 |
| 81 | Abnormality of complement system (HP:0005339) | 2.03506715 |
| 82 | Malnutrition (HP:0004395) | 2.03293859 |
| 83 | Peritonitis (HP:0002586) | 2.02493726 |
| 84 | Broad face (HP:0000283) | 2.01907654 |
| 85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01444008 |
| 86 | Emphysema (HP:0002097) | 2.00085540 |
| 87 | Meningitis (HP:0001287) | 1.99840903 |
| 88 | Arterial tortuosity (HP:0005116) | 1.99183907 |
| 89 | Hypercholesterolemia (HP:0003124) | 1.98975509 |
| 90 | Pseudobulbar signs (HP:0002200) | 1.98554716 |
| 91 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98197475 |
| 92 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98197475 |
| 93 | Viral hepatitis (HP:0006562) | 1.97453554 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 1.97371967 |
| 95 | Mucopolysacchariduria (HP:0008155) | 1.96644816 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96644816 |
| 97 | Prolonged bleeding time (HP:0003010) | 1.96509189 |
| 98 | Amyloidosis (HP:0011034) | 1.95965369 |
| 99 | Hyperacusis (HP:0010780) | 1.93415403 |
| 100 | Purpura (HP:0000979) | 1.93209822 |
| 101 | Aneurysm (HP:0002617) | 1.92576136 |
| 102 | Thrombocytosis (HP:0001894) | 1.92484816 |
| 103 | Hypoglycemic coma (HP:0001325) | 1.92460419 |
| 104 | Hepatitis (HP:0012115) | 1.92277985 |
| 105 | Gastrointestinal infarctions (HP:0005244) | 1.91862260 |
| 106 | Thrombophlebitis (HP:0004418) | 1.91589552 |
| 107 | Abnormality of the intrinsic pathway (HP:0010989) | 1.90159118 |
| 108 | Abnormality of T cell physiology (HP:0011840) | 1.88449305 |
| 109 | Hyperammonemia (HP:0001987) | 1.87734602 |
| 110 | Chronic diarrhea (HP:0002028) | 1.86855490 |
| 111 | Hypochromic anemia (HP:0001931) | 1.85510476 |
| 112 | Hepatocellular carcinoma (HP:0001402) | 1.85093384 |
| 113 | Mitral valve prolapse (HP:0001634) | 1.84864882 |
| 114 | Lymphopenia (HP:0001888) | 1.84771821 |
| 115 | Vasculitis (HP:0002633) | 1.84725684 |
| 116 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.83725845 |
| 117 | Fat malabsorption (HP:0002630) | 1.83504880 |
| 118 | Vertebral compression fractures (HP:0002953) | 1.82975166 |
| 119 | Interstitial pulmonary disease (HP:0006530) | 1.81839797 |
| 120 | Keratoconjunctivitis sicca (HP:0001097) | 1.81284747 |
| 121 | Abnormality of the lumbar spine (HP:0100712) | 1.80622816 |
| 122 | Pulmonary embolism (HP:0002204) | 1.80284084 |
| 123 | Menorrhagia (HP:0000132) | 1.79979931 |
| 124 | Polygenic inheritance (HP:0010982) | 1.78968989 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.78898703 |
| 126 | Joint swelling (HP:0001386) | 1.78566824 |
| 127 | Vascular tortuosity (HP:0004948) | 1.78399821 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78395873 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78395873 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78395873 |
| 131 | Pulmonary infiltrates (HP:0002113) | 1.78369133 |
| 132 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.78260824 |
| 133 | Dilatation of the ascending aorta (HP:0005111) | 1.78060347 |
| 134 | Abnormality of carpal bone ossification (HP:0006257) | 1.77635566 |
| 135 | Recurrent skin infections (HP:0001581) | 1.77588532 |
| 136 | Recurrent bacterial skin infections (HP:0005406) | 1.77583200 |
| 137 | Syringomyelia (HP:0003396) | 1.77264097 |
| 138 | Spinal cord lesions (HP:0100561) | 1.77264097 |
| 139 | Macroorchidism (HP:0000053) | 1.77250033 |
| 140 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.77199053 |
| 141 | Cervical subluxation (HP:0003308) | 1.76110198 |
| 142 | Ulnar bowing (HP:0003031) | 1.76023655 |
| 143 | Hemorrhage of the eye (HP:0011885) | 1.74032467 |
| 144 | Dislocated radial head (HP:0003083) | 1.73687727 |
| 145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73216143 |
| 146 | Abnormality of the thoracic spine (HP:0100711) | 1.73063896 |
| 147 | Abnormal ossification of hand bones (HP:0005921) | 1.71712267 |
| 148 | Coarse hair (HP:0002208) | 1.69304235 |
| 149 | Osteomyelitis (HP:0002754) | 1.66727616 |
| 150 | Obstructive lung disease (HP:0006536) | 1.63995326 |
| 151 | Chronic obstructive pulmonary disease (HP:0006510) | 1.63995326 |
| 152 | Cupped ribs (HP:0000887) | 1.61094177 |
| 153 | Abnormal tarsal ossification (HP:0008369) | 1.58637127 |
| 154 | Increased serum ferritin (HP:0003281) | 1.57723953 |
| 155 | Bone pain (HP:0002653) | 1.57413067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.63121140 |
| 2 | MAP4K1 | 3.53657756 |
| 3 | EEF2K | 3.44802758 |
| 4 | MAP3K10 | 3.40946612 |
| 5 | TRIB3 | 3.22725947 |
| 6 | PKN2 | 3.16624225 |
| 7 | FGFR4 | 2.82805136 |
| 8 | TYK2 | 2.58220510 |
| 9 | ERN1 | 2.51413748 |
| 10 | PTK6 | 2.26924232 |
| 11 | SIK1 | 2.20785872 |
| 12 | JAK3 | 2.12149682 |
| 13 | STK10 | 2.09358770 |
| 14 | JAK1 | 2.06594784 |
| 15 | GRK6 | 2.05398575 |
| 16 | CDK12 | 2.03978180 |
| 17 | SMG1 | 1.86428436 |
| 18 | FGFR3 | 1.72821837 |
| 19 | LRRK2 | 1.68785647 |
| 20 | MAP2K3 | 1.67772997 |
| 21 | FLT3 | 1.63678998 |
| 22 | EPHB1 | 1.58373344 |
| 23 | ITK | 1.54419942 |
| 24 | RIPK1 | 1.51744960 |
| 25 | TBK1 | 1.49579001 |
| 26 | TTN | 1.48312047 |
| 27 | ZAP70 | 1.44997806 |
| 28 | MAP3K14 | 1.44327998 |
| 29 | MAP3K13 | 1.40807154 |
| 30 | BTK | 1.39497769 |
| 31 | TAOK3 | 1.35242864 |
| 32 | CSF1R | 1.33685030 |
| 33 | CDC42BPA | 1.33508157 |
| 34 | TGFBR2 | 1.29353194 |
| 35 | SIK2 | 1.21853335 |
| 36 | JAK2 | 1.18833730 |
| 37 | MAP3K1 | 1.16630509 |
| 38 | IKBKE | 1.14565756 |
| 39 | MAP3K7 | 1.13068537 |
| 40 | RPS6KB2 | 1.05634974 |
| 41 | CSK | 1.01840578 |
| 42 | MARK2 | 1.01754904 |
| 43 | KSR2 | 1.00914724 |
| 44 | IKBKB | 0.97875972 |
| 45 | HCK | 0.97429816 |
| 46 | KIT | 0.96341013 |
| 47 | CHUK | 0.96242153 |
| 48 | FGR | 0.94886240 |
| 49 | TAOK2 | 0.94728452 |
| 50 | MST1R | 0.94459406 |
| 51 | CDK6 | 0.94293817 |
| 52 | TAOK1 | 0.93975330 |
| 53 | PDGFRA | 0.92451992 |
| 54 | RPS6KA4 | 0.88532567 |
| 55 | MAPK11 | 0.87915145 |
| 56 | PIM1 | 0.87605826 |
| 57 | MAP3K2 | 0.87255775 |
| 58 | TXK | 0.86996135 |
| 59 | MTOR | 0.86990826 |
| 60 | CAMK1D | 0.86849581 |
| 61 | EPHA3 | 0.86204812 |
| 62 | CDK4 | 0.85856809 |
| 63 | LCK | 0.85560672 |
| 64 | SYK | 0.84875301 |
| 65 | NEK2 | 0.83228077 |
| 66 | MAP3K6 | 0.79857651 |
| 67 | FES | 0.78378302 |
| 68 | ALK | 0.77981899 |
| 69 | MAP3K3 | 0.77896279 |
| 70 | PRKD2 | 0.76425932 |
| 71 | WNK1 | 0.73684791 |
| 72 | RET | 0.73261838 |
| 73 | MARK3 | 0.72234314 |
| 74 | STK4 | 0.72001272 |
| 75 | PTK2 | 0.68647835 |
| 76 | SGK3 | 0.68023952 |
| 77 | SIK3 | 0.67792685 |
| 78 | SCYL2 | 0.67688860 |
| 79 | DDR2 | 0.67632177 |
| 80 | IRAK3 | 0.65021430 |
| 81 | MAP3K11 | 0.64403858 |
| 82 | IRAK1 | 0.64265942 |
| 83 | CAMK1G | 0.64242241 |
| 84 | PRKAA2 | 0.64194113 |
| 85 | YES1 | 0.63229336 |
| 86 | TYRO3 | 0.63096000 |
| 87 | MAP3K8 | 0.62740179 |
| 88 | RPS6KL1 | 0.62507252 |
| 89 | RPS6KC1 | 0.62507252 |
| 90 | PDGFRB | 0.61329659 |
| 91 | MAPK7 | 0.61254224 |
| 92 | PAK4 | 0.60814624 |
| 93 | MATK | 0.60694044 |
| 94 | RPS6KA2 | 0.60204980 |
| 95 | KDR | 0.59347927 |
| 96 | PDK1 | 0.59219473 |
| 97 | TEC | 0.57593558 |
| 98 | PRKCH | 0.56510512 |
| 99 | DYRK1B | 0.54215089 |
| 100 | BLK | 0.53990890 |
| 101 | IRAK2 | 0.53371624 |
| 102 | BRD4 | 0.52269891 |
| 103 | TGFBR1 | 0.52052130 |
| 104 | MAPKAPK3 | 0.51435393 |
| 105 | BCKDK | 0.51193773 |
| 106 | FGFR1 | 0.50966768 |
| 107 | MELK | 0.50852886 |
| 108 | NEK9 | 0.48498841 |
| 109 | EPHA2 | 0.48029736 |
| 110 | AKT3 | 0.46452610 |
| 111 | TRPM7 | 0.46232520 |
| 112 | BMX | 0.45942229 |
| 113 | NLK | 0.45137370 |
| 114 | TNK2 | 0.44936826 |
| 115 | FGFR2 | 0.43364095 |
| 116 | CDK9 | 0.40889103 |
| 117 | EGFR | 0.39129660 |
| 118 | STK3 | 0.38801513 |
| 119 | MAP2K2 | 0.38217893 |
| 120 | LYN | 0.38199519 |
| 121 | PDPK1 | 0.38009339 |
| 122 | LATS1 | 0.37829024 |
| 123 | IRAK4 | 0.36978039 |
| 124 | PAK2 | 0.36056880 |
| 125 | RIPK4 | 0.35953298 |
| 126 | PRKCQ | 0.35832910 |
| 127 | HIPK2 | 0.34560752 |
| 128 | ICK | 0.33884409 |
| 129 | MAPK12 | 0.32220568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15578046 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93676746 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.83148471 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.55890636 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.29627911 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25410097 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.07608291 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01358327 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.94808687 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86767394 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86585062 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.83226271 |
| 13 | Lysine degradation_Homo sapiens_hsa00310 | 1.71108413 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66801047 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51696900 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50662594 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.47266897 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38569454 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35511534 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33982568 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.33842033 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.27432632 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26713035 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.25170118 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.24225796 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21513210 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20719731 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.18419813 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.18083962 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17035205 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16399888 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14460437 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12810708 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11940233 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.11569537 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.11416013 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11329048 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10085230 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09778668 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07154472 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.06563279 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06133589 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.05271459 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04201386 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02180254 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99522523 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95113207 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 0.94325785 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94028183 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.93910309 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93542080 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93150759 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91987121 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91434275 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90338846 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86879762 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86158840 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85688314 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85336538 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85335916 |
| 61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85331263 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.85077677 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.84983445 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84306479 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83942191 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83110241 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82421315 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82141607 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81971597 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81060467 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.80819261 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80710102 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79803341 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79587898 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79213200 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78437308 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78122491 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77918296 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.77651803 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76729044 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.76724723 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76413506 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76322652 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75866290 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74251065 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74010082 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72820293 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71804913 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.71371090 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70532050 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.70334924 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70209678 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69178959 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69173717 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.68646256 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67971397 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67367458 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66518738 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65787813 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65524620 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65488253 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65411943 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.65318585 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.65069184 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.64770680 |
| 106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64501780 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63859852 |
| 108 | Hepatitis B_Homo sapiens_hsa05161 | 0.63603375 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63330671 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62760087 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62699874 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62629216 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62285169 |
| 114 | Shigellosis_Homo sapiens_hsa05131 | 0.61937071 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60929936 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59644547 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59585558 |
| 118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59335262 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59181387 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.58686892 |
| 121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58680963 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.57988019 |
| 123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57664290 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56933129 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.56562907 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56153276 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.55605775 |
| 128 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55202394 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.55183589 |
| 130 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54454360 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54203423 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54012662 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53974441 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53893459 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53516429 |
| 136 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52989803 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52603327 |
| 138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51956847 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51896808 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51134389 |
| 141 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50461060 |
| 142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49564059 |
| 143 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47061014 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46439611 |

